Brain scans may predict antipsychotic success in First-Episode psychosis
NCT ID NCT07483294
First seen Mar 20, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study looks at brain scans of 120 people experiencing their first episode of psychosis to see if certain brain connections can predict how well they will respond to standard antipsychotic medications. Participants receive either risperidone or aripiprazole for 12 weeks, and their brain activity is measured before and after treatment. The goal is to find markers that help doctors choose the right treatment earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOSIS; ACUTE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zucker Hillside Hospital
RECRUITINGGlen Oaks, New York, 11004, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.